Fox Run Management, L.L.C. Puma Biotechnology, Inc. Transaction History

Fox Run Management, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $78,305 - $129,264	-12,047 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$8.75 - $12.85 $105,411 - $154,803	12,047 New	12,047 $130,000
Q2 2019 Jul 17, 2019	SELL	$12.3 - $35.76 $184,881 - $537,508	-15,031 Closed	0 $0
Q1 2019 Oct 17, 2019	SELL	$20.77 - $42.37 $88,417 - $180,369	-4,257 Reduced 22.07%	15,031 $583,000
Q4 2018 Jan 15, 2019	BUY	$20.07 - $46.7 $145,005 - $337,407	7,225 Added 59.89%	19,288 $393,000
Q3 2018 Oct 05, 2018	BUY	$41.2 - $59.85 $496,995 - $721,970	12,063 New	12,063 $553,000
Q4 2017 Jan 18, 2018	SELL	$93.85 - $132.45 $262,780 - $370,859	-2,800 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$72.0 - $119.75 $201,600 - $335,300	2,800	2,800 $335,000

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.